Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 6/20 | 0.36 |
| ▸ | TSHR | P16473 | 1/20 | 0.36 |
| ▸ | HPGD | P15428 | 2/20 | 0.35 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.35 |
| ▸ | HTR7 | P34969 | 1/20 | 0.34 |
| ▸ | AR | P10275 | 3/20 | 0.33 |
| ▸ | GAA | P10253 | 2/20 | 0.33 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.33 |
| ▸ | ADRB1 | P08588 | 1/20 | 0.33 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.33 |
| ▸ | GLA | P06280 | 1/20 | 0.33 |
| ▸ | ATM | Q13315 | 1/20 | 0.33 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.33 |
| ▸ | MEN1 | O00255 | 2/20 | 0.33 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.33 |
| ▸ | MAPT | P10636 | 4/20 | 0.33 |
| ▸ | LMNA | P02545 | 1/20 | 0.33 |
| ▸ | HTT | P42858 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL25049843 | 0.84 | ALDH1A1 (0.34) | ALDH1A1TSHRHPGDSMN1; SMN2AR | |
| SCHEMBL12392996 | 0.81 | ALDH1A1 (0.38) | ALDH1A1TSHRHPGDSMN1; SMN2HTR7 | |
| SCHEMBL26164095 | 0.75 | ALDH1A1 (0.40) | ALDH1A1HPGDSMN1; SMN2HTR7ADRB1 | |
| SCHEMBL15397099 | 0.73 | ALDH1A1 (0.39) | ALDH1A1TSHRHPGDSMN1; SMN2AR | |
| SCHEMBL16220756 | 0.73 | ALDH1A1 (0.39) | ALDH1A1TSHRHPGDSMN1; SMN2AR | |
| SCHEMBL12643067 | 0.73 | ALDH1A1 (0.39) | ALDH1A1TSHRHPGDSMN1; SMN2AR | |
| SCHEMBL26164094 | 0.72 | ALDH1A1 (0.35) | ALDH1A1GAAKDM4EATMMEN1 | |
| SCHEMBL17576293 | 0.71 | ALDH1A1 (0.36) | ALDH1A1TSHRHPGDSMN1; SMN2AR | |
| SCHEMBL15396987 | 0.71 | ALDH1A1 (0.36) | ALDH1A1TSHRHPGDSMN1; SMN2AR | |
| SCHEMBL19230062 | 0.71 | ALDH1A1 (0.36) | ALDH1A1TSHRHPGDSMN1; SMN2AR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20220144869-A1 | HETEROLEPTIC CARBENE COMPLEXES AND THE USE THEREOF IN ORGANIC ELECTRONICS | UDC IRELAND LIMITED (IE) | 2022-05-12 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220144869-A1 | HETEROLEPTIC CARBENE COMPLEXES AND THE USE THEREOF IN ORGANIC ELECTRONICS | OCIAD2, OCIAD1, CLTB | ALDH1A1 3145/4885TSHR 2038/4885HPGD 2569/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.